momenta pharmaceuticals inc
(MNTA:Consolidated Issue Listed on NASDAQ Global Select )
Marsha H. Fanucci
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee, Momenta Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 54 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Ms. Marsha H. Fanucci served as Senior Vice President and Chief Financial Officer of Millennium Pharmaceuticals Inc., from July 2004 to 2000 and also served as its Principal Accounting Officer. Ms. Fanucci served as Senior Vice President, Finance and Corporate Strategy of Millennium Pharmaceuticals Inc. from October 2003 to July 2004, Vice President of Finance and Corporate Strategy from July 2003 to October 2003 and Vice President, Corporate Development from July 2000 ...
675 West Kendall StreetPhone: 617-491-9700
Cambridge, Massachusetts 02142
Board Members Memberships*
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Director and Chairman of Audit Committee
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
West Virginia University School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Friedhelm Blobel Ph.D.||Chief Executive Officer, President, Executive Director and Member of Business Development Committee|
SciClone Pharmaceuticals, Inc.
|Douglas A. Michels||Chief Executive Officer, President and Director|
OraSure Technologies, Inc.
|Peter S. Greenleaf||Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|Venkaiah Chowdary Nannapaneni M. Pharm M S||Chairman, Managing Director, Chairman of Allotment Committee, Member of Audit Committee, Member of Compensation Committee and Member of Investor Grievance Committee|
Natco Pharma Limited
|Douglas L. Drysdale||Chairman, Chief Executive Officer and President|
Pernix Therapeutics Holdings, Inc.
|--||Compensation as of Fiscal Year 2013.|